Literature DB >> 6095872

Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy.

F T Hakim, R Cranley, K S Brown, E D Eanes, L Harne, J J Oppenheim.   

Abstract

Progressive ankylosis (ank), a murine autosomal recessive mutation, produces an inflammatory joint disorder associated with intraarticular calcium hydroxyapatite deposition and culminates in fusion of the joints. Joints in the feet become stiffened and swollen with milky white fluid containing polymorphonuclear leukocytes, large mononuclear macrophage-like cells, and calcium hydroxyapatite. The joints develop a proliferative synovitis, sometimes associated with marginal erosions of the articular cartilage and periosteal bone. Subsequently, cartilaginous osteophytes, extending outward from the subchondral bone, bridge the margins of the joint and undergo ossification. The progressive ankylosis mutation provides a useful system for investigating calcium hydroxyapatite-associated arthropathies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095872     DOI: 10.1002/art.1780271212

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Extracting and Selecting Robust Radiomic Features from PET/MR Images in Nasopharyngeal Carcinoma.

Authors:  Pengfei Yang; Lei Xu; Zuozhen Cao; Yidong Wan; Yi Xue; Yangkang Jiang; Eric Yen; Chen Luo; Jing Wang; Yi Rong; Tianye Niu
Journal:  Mol Imaging Biol       Date:  2020-12       Impact factor: 3.488

2.  Mapping of six germ-cell-specific genes to mouse chromosomes.

Authors:  M Matsui; H Ichihara; S Kobayashi; H Tanaka; J Tsuchida; M Nozaki; Y Yoshimura; H Nojima; J M Rochelle; Y Nishimune; M M Taketo; M F Seldin
Journal:  Mamm Genome       Date:  1997       Impact factor: 2.957

Review 3.  Phosphocitrate as a potential therapeutic strategy for crystal deposition disease.

Authors:  H S Cheung
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.592

4.  Biochemical and genetic analysis of ANK in arthritis and bone disease.

Authors:  Kyle A Gurley; Richard J Reimer; David M Kingsley
Journal:  Am J Hum Genet       Date:  2006-10-16       Impact factor: 11.025

5.  Mutations in ANKH cause chondrocalcinosis.

Authors:  Adrian Pendleton; Michelle D Johnson; Anne Hughes; Kyle A Gurley; Andrew M Ho; Michael Doherty; Josh Dixey; Pierre Gillet; Damien Loeuille; Rodney McGrath; Antonio Reginato; Rita Shiang; Gary Wright; Patrick Netter; Charlene Williams; David M Kingsley
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

Review 6.  Animal models of ankylosing spondylitis.

Authors:  Yiping Zhang; Shuilang Shi; Christina Ciurli; A Robin Poole
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

7.  A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD).

Authors:  I-Ping Chen; Liping Wang; Xi Jiang; Hector Leonardo Aguila; Ernst J Reichenberger
Journal:  Hum Mol Genet       Date:  2010-12-13       Impact factor: 6.150

Review 8.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

9.  Introduction of a Phe377del mutation in ANK creates a mouse model for craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Chiachien J Wang; Sara Strecker; Boguslawa Koczon-Jaremko; Adele Boskey; Ernst J Reichenberger
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

10.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.

Authors:  Dympna Harmey; Lovisa Hessle; Sonoko Narisawa; Kristen A Johnson; Robert Terkeltaub; José Luis Millán
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.